Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TELA Bio (TELA) Enterprise Value (2018 - 2025)

TELA Bio has reported Enterprise Value over the past 8 years, most recently at -$50.8 million for Q4 2025.

  • Quarterly results put Enterprise Value at -$50.8 million for Q4 2025, up 3.46% from a year ago — trailing twelve months through Dec 2025 was -$50.8 million (up 3.46% YoY), and the annual figure for FY2025 was -$50.8 million, up 3.46%.
  • Enterprise Value for Q4 2025 was -$50.8 million at TELA Bio, down from -$29.7 million in the prior quarter.
  • Over the last five years, Enterprise Value for TELA hit a ceiling of -$17.3 million in Q3 2024 and a floor of -$65.8 million in Q1 2021.
  • Median Enterprise Value over the past 5 years was -$43.4 million (2021), compared with a mean of -$43.6 million.
  • Biggest five-year swings in Enterprise Value: tumbled 135.4% in 2023 and later soared 70.27% in 2024.
  • TELA Bio's Enterprise Value stood at -$43.9 million in 2021, then grew by 4.35% to -$42.0 million in 2022, then decreased by 11.21% to -$46.7 million in 2023, then decreased by 12.71% to -$52.7 million in 2024, then grew by 3.46% to -$50.8 million in 2025.
  • The last three reported values for Enterprise Value were -$50.8 million (Q4 2025), -$29.7 million (Q3 2025), and -$35.0 million (Q2 2025) per Business Quant data.